Emergency medicine is, by its nature, borne out of necessity and through painful
lessons that specialized care is required for many patients presenting to hospital “ERs”
with complaints ranging from minor ailments to life threatening illness and even in
Cervical cancer is the second most prevalent cancer among women worldwide, and infection with Human Papilloma Virus (HPV) has been identified as the causal agent for this condition. The natural history of cervical cancer is characterized by slow disease progression, rendering the condition in essence preventable and even treatable when diagnosed in early stages.
The RRL also conducts analysis of r-value or vaccine matching of field isolates in
comparison with relevant vaccine strains. In terms of serology, the RRL routinely uses liquid
phase blocking (LP) and non structure protein (NSP) ELISA. It has been involved in several
validation tests conducted for NSP ELISA under the IAEA Project. In addition, the RRL
routinely produces and supplies the FMD diagnostic reagents to laboratories both within
Thailand as well as SEAFMD countries.
The FAO projects, through supporting virological surveillance, assisted identifying in
Pakistan the Asia-1 strain not matched to the Shamir vaccine; the early warning to WELNET
assisted when the first evidence of spread to the west was detected, and willingness to share
isolates assisted in vaccine development (FMD Institute Ankara) for local use.
The Roadmap assessment and peer review system has encouraged reporting of serological
findings but FMD remains highly sensitive and the move towards open and transparent
reporting of findings across the region is a challenge.
Children, especially those in groups, are more likely to get infectious diseases than are adults. As a
childcare provider, you will be exposed to infectious diseases more frequently than will someone
who has less contact with children. To protect yourself and children in your care, you need to know
what immunizations you received as a child and whether you had certain childhood diseases. If
you are not sure, your health care provider can test your blood to determine if you are immune to
some of these diseases and can vaccinate you against those to which you are...
In the 1980s and early 1990s, receiving news that one
was infected with HIV was a literal death sentence.
No vaccine or cure for AIDS exists. Back then, people
with HIV could expect to become ill with AIDS within
about ten years after becoming infected, and then live
only one to two years on average after that. The virus destroys
immune cells, leaving those infected vulnerable to
a whole host of opportunistic infections. Eventually, one
of them causes death.
"Although data concerning the response of pediatric hemodialysis patients to vaccination
with standard pediatric doses are lacking, protective levels of antibody occur in 75% -97% of
those who receive higher dosages (20-µg) on either the 3- or the 4-dose schedule."5
"Limited data are available on the duration of immune memory after hepatitis B vaccina
tion in . . . dialysis patients. No clinically important HBV infections have been documented
among immunocompromised persons who maintain protective levels of anti-HBs....
Since 2005, the international development
perspectives have broadened, with new funding
sources, partnerships and configurations of
stakeholders. Global public-health initiatives
such as the Global Alliance for Vaccines and
Immunisation (GAVI) and the Global Fund to fight
AIDS, Tuberculosis and Malaria (GFATM) have
matured their operations and increasingly become
significant sources of revenue for national health
budgets in many low-income countries.